Welcome to UCL Cancer Institute 

The UCL Cancer Institute is the hub for cancer research at University College London, one of the World's leading universities. The Institute draws together over 300 talented scientists who are working together to translate research discoveries into developing kinder, more effective therapies for cancer patients. If you are thinking about studying with us, applications to our flagship MSc Cancer postgraduate programme and our new undergraduate degree BSc Cancer Biomedicine, are now open to application for September 2018 start. 

News and features

Tumour Heterogeneity Team wins Cancer Research UK Translational Cancer Research Prize 2017

The Tumour Heterogeneity Team, led by Professor Charles Swanton, has been awarded the Cancer Research UK Translational Research Prize at the National Cancer Research Institute (NCRI) conference 2017. This prize recognises the cutting edge breakthroughs of an outstanding research team that has united in the quest to ensure scientific discoveries benefit patients and the public.

Published: Dec 11, 2017 4:26:10 PM

Experimental model to study the development of brain cancer in children

Researchers from UCL, the German Center for Neurodegenerative Diseases (DZNE) and McGill University, Montreal have published details of a novel laboratory model that replicates the hallmarks of paediatric brain cancer. The research results, published in Cancer Cell, could pave the way for a better understanding of processes driving the development of cancer.

Published: Oct 31, 2017 11:09:38 AM

Rucaparib boosts progression-free survival in recurrent ovarian cancer

The highly anticipated results from the ARIEL3 clinical trial, evaluating use of rucaparib among women with advanced ovarian cancer, have been published in The Lancet. According to study data, maintenance therapy with rucaparib (Rubraca, Clovis Oncology) significantly extended progression-free survival among women with platinum-sensitive recurrent ovarian cancer. 

Published: Oct 1, 2017 2:29:11 PM

First prostate cancer patient scanned using hyperpolarised MRI in Europe

A University College Hospital prostate cancer patient has undergone diagnosis using hyperpolarised Magnetic Resonance Imaging (MRI) as part of a UCL clinical trial. Led by Dr Shonit Punwani, the trial aims to develop more accurate and personalised treatment for cancer.

Published: Aug 23, 2017 4:17:30 PM

Cancer Research UK-UCL Centre

Cancer Research UK-UCL Centre

The Cancer Research UK-UCL Centre is a network and partnership between Cancer Research UK, UCL and UCL's associated Hospital Trusts. The Centre's mission is to facilitate collaboration to advance world-class translational cancer research.

Study with us

Study with us

Our education programmes reflect the depth and breadth of research expertise within the UCL Cancer Institute. Join our community of research scientists and academic clinicians through our postgraduate taught MSc Cancer or PhD studies.

Clinical Trials

Clinical Trials

The Cancer Research UK and UCL Cancer Trials Centre is one of the largest cancer trials centres in the UK. The CTC conducts multi-centre national and international phase III trials, feasibility studies and early phase I and II studies.

Our Research

Our Research

UCL is a world leader in interdisciplinary research. The UCL Cancer Institute is uniquely placed to leverage this multidisciplinary approach to advance discoveries in basic, translational and clinical cancer research.


UCL Cancer Institute Special Seminar

Prof Luciano di Croce, Centre for Genomic Regulation, Barcelona presents: The biological role of Polycomb and MLL complexes in stem cells and cancer.

Starts: Dec 14, 2017 12:00:00 PM

Support our work

GCLP lab

Help us to continue the research that will lead to the breakthroughs in therapies for cancer patients. Support us >

Action for equality and diversity 

Athena SWAN Silver Award

UCL Cancer Institute is proud to hold an Athena SWAN silver award in recognition of our commitment to advancing equality, diversity and inclusion. 

Learn more about Athena SWAN initiatives >

Connect with us